Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Comparison of Local Injection of Fresh Frozen Plasma to Traditional Methods of Hemostasis in Minimally Invasive Procedures.

Haaga J, Rahim S, Kondray V, Davidson J, Patel I, Nakamoto D.

Acad Radiol. 2018 Mar 22. pii: S1076-6332(18)30112-0. doi: 10.1016/j.acra.2018.03.001. [Epub ahead of print]

PMID:
29573937
2.

Early stage aggregation of a coarse-grained model of polyglutamine.

Haaga J, Gunton JD, Buckles CN, Rickman JM.

J Chem Phys. 2018 Jan 28;148(4):045106. doi: 10.1063/1.5010888.

PMID:
29390859
3.

Efficiency of combined blocking of aerobic and glycolytic metabolism pathways in treatment of N1-S1 hepatocellular carcinoma in a rat model.

Yarmohammadi H, Wilkins LR, Erinjeri JP, Novak RD, Exner AA, Wu H, Petre EN, Boas E, Ziv E, Haaga JR.

J Cancer Res Ther. 2017 Jul-Sep;13(3):533-537. doi: 10.4103/0973-1482.172127.

4.

Pyogenic liver abscesses: a contemporary analysis of management strategies at a tertiary institution.

Rismiller K, Haaga J, Siegel C, Ammori JB.

HPB (Oxford). 2017 Oct;19(10):889-893. doi: 10.1016/j.hpb.2017.06.005. Epub 2017 Jul 8.

5.

Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.

Wilkins LR, Brautigan DL, Wu H, Yarmohammadi H, Kubicka E, Serbulea V, Leitinger N, Liu W, Haaga JR.

Cardiovasc Intervent Radiol. 2017 Mar;40(3):430-437. doi: 10.1007/s00270-016-1515-y. Epub 2016 Nov 21.

6.

Direct Injection of Blood Products Versus Gelatin Sponge as a Technique for Local Hemostasis.

Haaga J, Rahim S.

Cardiovasc Intervent Radiol. 2017 Feb;40(2):231-235. doi: 10.1007/s00270-016-1494-z. Epub 2016 Nov 8.

PMID:
27826788
7.

Phase diagram of a model of the protein amelogenin.

Haaga J, Pemberton E, Gunton JD, Rickman JM.

J Chem Phys. 2016 Aug 28;145(8):085105. doi: 10.1063/1.4961597.

PMID:
27586954
8.

Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.

Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ.

Radiother Oncol. 2015 Oct;117(1):183-7. doi: 10.1016/j.radonc.2015.08.030. Epub 2015 Sep 8.

PMID:
26362723
9.

Kinetics of aggregation of an anisotropic model of self-assembling molecules.

Khan S, Haaga J, Gunton JD.

J Chem Phys. 2015 Jul 14;143(2):024906. doi: 10.1063/1.4926537.

PMID:
26178126
10.

Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.

Malamas AS, Jin E, Zhang Q, Haaga J, Lu ZR.

Pharm Res. 2015 Sep;32(9):3029-43. doi: 10.1007/s11095-015-1684-4. Epub 2015 Apr 4.

11.

ALPHA glycolytic vasculogenesis better correlates with MRI and CT imaging techniques than the traditional oxygen vasculogenesis theory.

Haaga JR, Haaga R, Patel I, Love Z, Moulter J.

AJR Am J Roentgenol. 2014 Dec;203(6):W724-34. doi: 10.2214/AJR.13.11762. Review.

PMID:
25415739
12.

Squamous cell carcinoma arising from ovarian mature cystic teratoma and causing small bowel obstruction.

Yarmohammadi H, Mansoori B, Wong V, Tacher V, Wilkins LR, Pavlidakey PG, Haaga JR.

J Cancer Res Ther. 2014 Jul-Sep;10(3):770-2. doi: 10.4103/0973-1482.136051.

13.

Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience.

Hartman JB, Bhojwani N, Corn DJ, Cooney MM, Haaga J, Ponsky L, Abouassaly R, Paspulati A, Prologo JD.

J Vasc Interv Radiol. 2014 May;25(5):776-9. doi: 10.1016/j.jvir.2014.01.027. Epub 2014 Mar 18.

14.

Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model.

Wu H, Wilkins LR, Ziats NP, Haaga JR, Exner AA.

Radiology. 2014 Jan;270(1):107-16. doi: 10.1148/radiol.13121999. Epub 2013 Oct 28.

16.

Pneumodissection: an alternative protective technique for the percutaneous cryoablation of small renal masses.

Maurice MJ, Haaga JR, Nakamoto DA, Ponsky LE.

Urol Int. 2013;90(4):381-3. doi: 10.1159/000346332. Epub 2013 Apr 9.

PMID:
23594736
17.

Image-guided biopsy of small renal masses in the era of ablative therapies.

Salem S, Ponsky LE, Abouassaly R, Cherullo EE, Isariyawongse JP, Maclennan GT, Nakamoto D, Haaga JR.

Int J Urol. 2013 Jun;20(6):580-4. doi: 10.1111/iju.12010. Epub 2012 Nov 27.

18.

Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.

Wilkins LR, Wu H, Haaga JR, Exner A.

J Vasc Interv Radiol. 2012 Jun;23(6):826-32. doi: 10.1016/j.jvir.2012.02.010. Epub 2012 Apr 14.

19.

Percutaneous computed tomography guided cryoablation of the celiac plexus as an alternative treatment for intractable pain caused by pancreatic cancer.

Yarmohammadi H, Nakamoto DA, Azar N, Hayek SM, Haaga JR.

J Cancer Res Ther. 2011 Oct-Dec;7(4):481-3. doi: 10.4103/0973-1482.92024.

20.

Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.

Wu H, Patel RB, Zheng Y, Solorio L, Krupka TM, Ziats NP, Haaga JR, Exner AA.

Ultrasound Med Biol. 2012 Mar;38(3):443-53. doi: 10.1016/j.ultrasmedbio.2011.12.008. Epub 2012 Jan 21.

21.

Hemostasis effects of direct intraparenchymal injection of platelets and fresh frozen plasma before cutting needle biopsy in an animal model.

Nakamoto DA, Wilkins LR, Haaga JR.

J Vasc Interv Radiol. 2011 Nov;22(11):1601-5. doi: 10.1016/j.jvir.2011.07.017. Epub 2011 Sep 15.

PMID:
21924625
22.

Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes.

Vricella GJ, Haaga JR, Adler BL, Dean Nakamoto, Cherullo EE, Flick S, Ponsky LE.

Urology. 2011 Mar;77(3):649-54. doi: 10.1016/j.urology.2010.08.016. Epub 2010 Dec 24.

PMID:
21185065
23.

Reproductive aging: theoretical perspectives, mechanisms, nonhuman models, and health correlates.

Haaga J, O'Connor K, Weinstein M, Wise P.

Ann N Y Acad Sci. 2010 Aug;1204:1-10. doi: 10.1111/j.1749-6632.2010.05700.x.

PMID:
20738270
24.

Hypoxia--implications for pharmaceutical developments.

Donovan L, Welford SM, Haaga J, LaManna J, Strohl KP.

Sleep Breath. 2010 Dec;14(4):291-8. doi: 10.1007/s11325-010-0368-x. Epub 2010 Jul 14. Review.

25.
26.

Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.

Wu H, Exner AA, Krupka TM, Weinberg BD, Patel R, Haaga JR.

Acad Radiol. 2009 Mar;16(3):321-31. doi: 10.1016/j.acra.2008.09.008.

27.

Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size.

Wu H, Exner AA, Krupka TM, Weinberg BD, Haaga JR.

Ann Biomed Eng. 2009 Mar;37(3):552-64. doi: 10.1007/s10439-008-9605-x. Epub 2008 Dec 16.

28.

Tissue-based research in kidney cancer: current challenges and future directions.

Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB.

Clin Cancer Res. 2008 Jun 15;14(12):3699-705. doi: 10.1158/1078-0432.CCR-07-4733. Review.

29.

Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model.

Weinberg BD, Krupka TM, Haaga JR, Exner AA.

Radiology. 2008 Mar;246(3):796-803. doi: 10.1148/radiol.2463070228.

PMID:
18309015
30.

Injectable polymer depot combined with radiofrequency ablation for treatment of experimental carcinoma in rat.

Krupka TM, Weinberg BD, Ziats NP, Haaga JR, Exner AA.

Invest Radiol. 2006 Dec;41(12):890-7.

PMID:
17099428
31.

Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.

Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RJ, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS.

J Urol. 2006 Nov;176(5):1973-7. Erratum in: J Urol. 2008 Jun;179(6):2490. Zagoria, Ronald A [corrected to Zagoria, Ronald J].

PMID:
17070224
32.

Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil.

Haaga JR, Exner A, Fei B, Seftel A.

Int J Impot Res. 2007 Jan-Feb;19(1):110-3. Epub 2006 May 25.

33.

Interventional CT: 30 years' experience.

Haaga JR.

Eur Radiol. 2005 Nov;15 Suppl 4:D116-20. Review.

PMID:
16479660
34.

Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits.

Haaga JR, Exner AA, Wang Y, Stowe NT, Tarcha PJ.

Radiology. 2005 Dec;237(3):911-8. Epub 2005 Oct 19.

PMID:
16237145
35.

Therapy-induced malignant neoplasms in Nf1 mutant mice.

Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J, Borowsky A, Horvai A, Kogan SC, Bonifas J, Huey B, Jacks TE, Albertson DG, Shannon KM.

Cancer Cell. 2005 Oct;8(4):337-48.

36.

Quantitative computed tomography analysis of local chemotherapy in liver tissue after radiofrequency ablation.

Exner AA, Weinberg BD, Stowe NT, Gallacher A, Wilson DL, Haaga JR, Gao J.

Acad Radiol. 2004 Dec;11(12):1326-36.

PMID:
15596370
37.

A feasibility study of high intensity focused ultrasound for liver biopsy hemostasis.

Deng CX, Dogra V, Exner AA, Wang H, Bhatt S, Zhou Y, Stowe NT, Haaga JR.

Ultrasound Med Biol. 2004 Nov;30(11):1531-7.

PMID:
15588964
38.

Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience.

Lewin JS, Nour SG, Connell CF, Sulman A, Duerk JL, Resnick MI, Haaga JR.

Radiology. 2004 Sep;232(3):835-45.

PMID:
15333798
39.

Emergent ultrasound interventions.

Nakamoto DA, Haaga JR.

Radiol Clin North Am. 2004 Mar;42(2):457-78. Review.

PMID:
15136028
40.

Computed Tomography-guided Drainage of Intra-abdominal Infections.

Haaga JR, Nakamoto D.

Curr Infect Dis Rep. 2004 Apr;6(2):105-114.

PMID:
15023272
41.

Local carboplatin delivery and tissue distribution in livers after radiofrequency ablation.

Szymanski-Exner A, Gallacher A, Stowe NT, Weinberg B, Haaga JR, Gao J.

J Biomed Mater Res A. 2003 Nov 1;67(2):510-6.

PMID:
14566792
42.

Noninvasive monitoring of local drug release using X-ray computed tomography: optimization and in vitro/in vivo validation.

Szymanski-Exner A, Stowe NT, Salem K, Lazebnik R, Haaga JR, Wilson DL, Gao J.

J Pharm Sci. 2003 Feb;92(2):289-96.

PMID:
12532379
43.

Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography.

Szymanski-Exner A, Stowe NT, Lazebnik RS, Salem K, Wilson DL, Haaga JR, Gao J.

J Control Release. 2002 Oct 30;83(3):415-25.

PMID:
12387949
44.

In vivo drug distribution dynamics in thermoablated and normal rabbit livers from biodegradable polymers.

Gao J, Qian F, Szymanski-Exner A, Stowe N, Haaga J.

J Biomed Mater Res. 2002 Nov;62(2):308-14.

PMID:
12209952
45.

CT-integrated robot for interventional procedures: preliminary experiment and computer-human interfaces.

Yanof J, Haaga J, Klahr P, Bauer C, Nakamoto D, Chaturvedi A, Bruce R.

Comput Aided Surg. 2001;6(6):352-9.

PMID:
11954066
46.

Greater collaboration across the disciplines: challenges and opportunities.

Weinstein M, Hermalin AI, Stoto MA, Evans VJ, Ewbank D, Haaga J, Ibrahim M, Madans J.

Ann N Y Acad Sci. 2001 Dec;954:311-21.

PMID:
11797863
47.

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

Dowlati A, Haaga J, Remick SC, Spiro TP, Gerson SL, Liu L, Berger SJ, Berger NA, Willson JK.

Clin Cancer Res. 2001 Oct;7(10):2971-6.

48.

Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine.

Liu L, Spiro TP, Qin X, Majka S, Haaga J, Schupp J, Willson JK, Gerson SL.

Clin Cancer Res. 2001 Aug;7(8):2318-24.

49.
50.

Radiation dose management: weighing risk versus benefit.

Haaga JR.

AJR Am J Roentgenol. 2001 Aug;177(2):289-91. No abstract available.

PMID:
11461847

Supplemental Content

Support Center